We are live on ! Find out more
XTNT icon

Xtant Medical Holdings
XTNT

17 hedge funds and large institutions have $89.4M invested in Xtant Medical Holdings in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2.54% less ownership

Funds ownership: 95.39% → 92.85% (-2.5%)

15% less funds holding

Funds holding: 20 → 17 (-3)

34% less capital invested

Capital invested by funds: $135M → $89.4M (-$45.5M)

43% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 7

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
17
Holders Change
-3
Holders Change %
-15%
% of All Funds
0.3%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
–
Increased
4
Reduced
7
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BCM
Bridgeway Capital Management
Texas
+$267K
2
TRCT
Tower Research Capital (TRC)
New York
+$30.5K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$5.29K
4
Wells Fargo
Wells Fargo
California
+$74

Top Sellers

Rank Fund Capital Flow
1
ACM
Altium Capital Management
New York
-$2.65M
2
Renaissance Technologies
Renaissance Technologies
New York
-$431K
3
Citadel Advisors
Citadel Advisors
Florida
-$60K
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$25K
5
VF
Virtu Financial
New York
-$15.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$80.9M – – –
ACM
2
Altium Capital Management
New York
$6.94M -$2.65M -2,038,144 -25%
Renaissance Technologies
3
Renaissance Technologies
New York
$756K -$431K -331,200 -33%
BCM
4
Bridgeway Capital Management
Texas
$550K +$267K +204,998 +70%
Vanguard Group
5
Vanguard Group
Pennsylvania
$54K +$5.29K +4,066 +9%
TRCT
6
Tower Research Capital (TRC)
New York
$35K +$30.5K +23,432 +285%
VF
7
Virtu Financial
New York
$27K -$15.6K -12,014 -33%
BlackRock
8
BlackRock
New York
$25K -$634 -488 -2%
State Street
9
State Street
Massachusetts
$25K – – –
Geode Capital Management
10
Geode Capital Management
Massachusetts
$23K – – –
HF
11
HRT Financial
New York
$22K -$1 -1 -0%
Victory Capital Management
12
Victory Capital Management
Texas
$14K -$845 -650 -5%
Citadel Advisors
13
Citadel Advisors
Florida
– -$60K -36,531 Closed
T. Rowe Price Associates
14
T. Rowe Price Associates
Maryland
– -$25K -15,472 Closed
Bank of America
15
Bank of America
North Carolina
– -$33 -25 -35%
Wells Fargo
16
Wells Fargo
California
– +$74 +57 +204%

XTNT Hedge Fund Activity: Q3 2021 in Review

17 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Xtant Medical Holdings (XTNT) for Q3 2021, worth a combined $89.4M — down 34% from $135M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of XTNT and 0 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 4 added.

The largest buyer was Bridgeway Capital Management, adding an estimated $267K. The largest seller was Altium Capital Management, cutting an estimated $2.65M.

  • 17 institutional investors held Xtant Medical Holdings (XTNT) as of Q3 2021, down from 20 in Q2 2021.
  • Funds reported $89.4M of Xtant Medical Holdings stock for Q3 2021, down 34% quarter-over-quarter.
  • 0 funds opened new Xtant Medical Holdings positions in Q3 2021 and 3 closed out, a net change of -3 holders.
  • The largest Xtant Medical Holdings buyer in Q3 2021 was Bridgeway Capital Management, an estimated $267K added.
  • The largest Xtant Medical Holdings seller in Q3 2021 was Altium Capital Management, an estimated $2.65M sold.

Based on aggregated 13F filings for Q3 2021.